scholarly journals Certolizumab pegol for the treatment of patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials

2018 ◽  
Vol 33 (3) ◽  
pp. 546-552 ◽  
Author(s):  
A. Blauvelt ◽  
K. Reich ◽  
M. Lebwohl ◽  
D. Burge ◽  
C. Arendt ◽  
...  
Keyword(s):  
Randomized Controlled Trials ◽  
Plaque Psoriasis ◽  
Certolizumab Pegol ◽  
Pooled Analysis ◽  
Controlled Trials ◽  
Chronic Plaque Psoriasis ◽  
Randomized Controlled

scholarly journals Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials

2018 ◽  
Vol 2 ◽  
pp. S3 ◽  
Author(s):  
Andrew Blauvelt ◽  
Kristian Reich ◽  
Mark Lebwohl ◽  
Daniel Burge ◽  
Catherine Arendt ◽  
...  
Keyword(s):  
Randomized Controlled Trials ◽  
Plaque Psoriasis ◽  
Certolizumab Pegol ◽  
Controlled Trials ◽  
Chronic Plaque Psoriasis ◽  
Randomized Controlled

Abstract not available. Disclosures: Study sponsored by UCB Pharma. Copyright 2018 SKIN

Sign in / Sign up

Export Citation Format

Share Document